Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Summary

Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platform development, has announced its participation in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. The company's management will engage in a fireside chat on June 10, 2025, at 2:00 p.m. Eastern Time. Investors and interested parties can access both live and archived webcasts of the presentation through the "Investors" section on Nautilus' website at www.nautilus.bio.

News Market Reaction – NAUT

+5.59%

+5.59% Session move

In the trading session that priced this news, NAUT gained 5.59%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46^th Annual Global Healthcare Conference.

Nautilus’ management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

When is Nautilus Biotechnology (NAUT) presenting at the Goldman Sachs Healthcare Conference 2025?

Nautilus Biotechnology will present at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time.

How can I watch Nautilus Biotechnology's (NAUT) presentation at the Goldman Sachs Conference?

You can watch the live and archived webcast of Nautilus' presentation through the 'Investors' section on their website at www.nautilus.bio.

What type of presentation will Nautilus Biotechnology (NAUT) give at the Goldman Sachs Conference?

Nautilus Biotechnology's management will participate in a fireside chat format presentation at the conference.

What is Nautilus Biotechnology's (NAUT) main business focus?

Nautilus Biotechnology is a company that pioneers a single-molecule protein analysis platform for quantifying the proteome.